Formulation Development and Characterization of Targeted Drug Delivery System for Breast Cancer

Cancer is one among the leading causes of death worldwide. Cancer cells proliferate at much faster rate than the normal cells. The available traditional cancer chemotherapy is not essentially selective as it depends on the kinetics of the cell growth.1Breast cancer is common lethal cause of malignancy among women around all the countries. Early detection of breast cancer facilitates the diagnosis and treatment prior to metastasis. Despite remarkable development in new medicine findings and therapies for carcinoma during previous decades, no significant treatment methods are accessible for cancer-affected people with invasive and metastatic carcinoma. During this stage, the patients have less response to cancer therapy thanks to recurrence properties of cancer.